BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3047024)

  • 1. Monocyte procoagulant activity as a peripheral marker of clotting activation in cancer patients.
    Morgan D; Edwards RL; Rickles FR
    Haemostasis; 1988; 18(1):55-65. PubMed ID: 3047024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity.
    Edwards RL; Levine JB; Green R; Duffy M; Mathews E; Brande W; Rickles FR
    Gastroenterology; 1987 Feb; 92(2):329-37. PubMed ID: 3792769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased procoagulant activity of peripheral blood monocytes in human and experimental obstructive jaundice.
    Semeraro N; Montemurro P; Chetta G; Altomare DF; Giordano D; Colucci M
    Gastroenterology; 1989 Mar; 96(3):892-8. PubMed ID: 2914650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of platelet on procoagulant activity of monocyte].
    Xu J; He X; Xiong S
    Zhonghua Xue Ye Xue Za Zhi; 2001 Sep; 22(9):478-80. PubMed ID: 11758230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study.
    Ernofsson M; Thelin S; Siegbahn A
    J Thorac Cardiovasc Surg; 1997 Mar; 113(3):576-84. PubMed ID: 9081105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte procoagulant activity in breast cancer.
    Auger MJ; Mackie MJ
    Thromb Res; 1987 Jul; 47(1):77-84. PubMed ID: 3660345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient intermittent lymphocyte activation is responsible for the instability of angina.
    Serneri GG; Abbate R; Gori AM; Attanasio M; Martini F; Giusti B; Dabizzi P; Poggesi L; Modesti PA; Trotta F
    Circulation; 1992 Sep; 86(3):790-7. PubMed ID: 1516190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition by pentoxifylline of procoagulant activity produced by endotoxin-active monocytes].
    de Prost D; Ollivier V; Hakim J
    C R Seances Soc Biol Fil; 1992; 186(3):186-92. PubMed ID: 1283564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and characterization of a monoclonal antibody (A1-3) that binds selectively to activated monocytes and inhibits monocyte procoagulant activity.
    Ewan VA; Cieplinski W; Hancock WW; Goldschneider I; Boyd AW; Rickles FR
    J Immunol; 1986 Apr; 136(7):2408-15. PubMed ID: 3950416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte procoagulant inducing factor: a lymphokine involved in the T cell-instructed monocyte procoagulant response to antigen.
    Gregory SA; Kornbluth RS; Helin H; Remold HG; Edgington TS
    J Immunol; 1986 Nov; 137(10):3231-9. PubMed ID: 2945864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endotoxin-induced procoagulant activity in equine peripheral blood monocytes.
    Henry MM; Moore JN
    Circ Shock; 1988 Nov; 26(3):297-309. PubMed ID: 3208423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term incubation with IL-4 and IL-10 oppositely modifies procoagulant activity of monocytes and modulates the surface expression of tissue factor and tissue factor pathway inhibitor.
    Paysant J; Soria C; Cornillet-Lefèbvre P; Nguyen P; Lenormand B; Mishal Z; Vannier JP; Vasse M
    Br J Haematol; 2005 Nov; 131(3):356-65. PubMed ID: 16225656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte IL-10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles.
    Poitevin S; Cochery-Nouvellon E; Dupont A; Nguyen P
    Thromb Haemost; 2007 Apr; 97(4):598-607. PubMed ID: 17393023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent cellular population of textured-surface left ventricular assist devices contributes to the development of a biphasic systemic procoagulant response.
    Spanier TB; Chen JM; Oz MC; Stern DM; Rose EA; Schmidt AM
    J Thorac Cardiovasc Surg; 1999 Sep; 118(3):404-13. PubMed ID: 10469951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation.
    Edwards RL; Rickles FR; Cronlund M
    J Lab Clin Med; 1981 Dec; 98(6):917-28. PubMed ID: 7310230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of procoagulant factors in mononuclear phagocytes.
    Dean RT; Leoni P; Rossi BC
    Haemostasis; 1984; 14(5):412-21. PubMed ID: 6398242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of serum on monocyte tissue factor generation.
    Edwards RL; Perla D
    Blood; 1984 Sep; 64(3):707-14. PubMed ID: 6235870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of monocyte-macrophage procoagulant activity by transformed cell lines.
    Rambaldi A; Alessio G; Casali B; Passerini CG; Donati MB; Mantovani A; Semeraro N
    J Immunol; 1986 May; 136(10):3848-55. PubMed ID: 3701063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood coagulation in patients with benign and malignant tumours before and after surgery. Special reference to thromboplastin generation in monocytes.
    Osterud B; Due J
    Scand J Haematol; 1984 Mar; 32(3):258-64. PubMed ID: 6199833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased blood monocyte procoagulant activity in cotton mill workers.
    Beijer L; Carvalheiro M; Holt PG; Rylander R
    J Clin Lab Immunol; 1990 Nov; 33(3):125-7. PubMed ID: 1967001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.